Global Drugs for Malaria Market Size, Status and Forecast 2022

Publisher Name :
Date: 10-Jan-2022
No. of pages: 95
Inquire Before Buying

Drugs for Malaria market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drugs for Malaria market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Aryl Aminoalcohol Compounds

- Antifolate Compounds

- Artemisinin Compounds

Segment by Application

- Prevention

- Treatment

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Cipla

- Guilin Pharmaceutical

- IPCA Laboratories

- GlaxoSmithKline

- Mylan Labs

- Roche

- Novartis

- Sanofi Aventis

- Ajanta Pharma

Global Drugs for Malaria Market Size, Status and Forecast 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Malaria Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Aryl Aminoalcohol Compounds
1.2.3 Antifolate Compounds
1.2.4 Artemisinin Compounds
1.3 Market by Application
1.3.1 Global Drugs for Malaria Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Prevention
1.3.3 Treatment
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Malaria Market Perspective (2016-2027)
2.2 Drugs for Malaria Growth Trends by Regions
2.2.1 Drugs for Malaria Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Drugs for Malaria Historic Market Share by Regions (2016-2021)
2.2.3 Drugs for Malaria Forecasted Market Size by Regions (2022-2027)
2.3 Drugs for Malaria Industry Dynamic
2.3.1 Drugs for Malaria Market Trends
2.3.2 Drugs for Malaria Market Drivers
2.3.3 Drugs for Malaria Market Challenges
2.3.4 Drugs for Malaria Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Malaria Players by Revenue
3.1.1 Global Top Drugs for Malaria Players by Revenue (2016-2021)
3.1.2 Global Drugs for Malaria Revenue Market Share by Players (2016-2021)
3.2 Global Drugs for Malaria Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Drugs for Malaria Revenue
3.4 Global Drugs for Malaria Market Concentration Ratio
3.4.1 Global Drugs for Malaria Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Malaria Revenue in 2020
3.5 Drugs for Malaria Key Players Head office and Area Served
3.6 Key Players Drugs for Malaria Product Solution and Service
3.7 Date of Enter into Drugs for Malaria Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Malaria Breakdown Data by Type
4.1 Global Drugs for Malaria Historic Market Size by Type (2016-2021)
4.2 Global Drugs for Malaria Forecasted Market Size by Type (2022-2027)
5 Drugs for Malaria Breakdown Data by Application
5.1 Global Drugs for Malaria Historic Market Size by Application (2016-2021)
5.2 Global Drugs for Malaria Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Drugs for Malaria Market Size (2016-2027)
6.2 North America Drugs for Malaria Market Size by Type
6.2.1 North America Drugs for Malaria Market Size by Type (2016-2021)
6.2.2 North America Drugs for Malaria Market Size by Type (2022-2027)
6.2.3 North America Drugs for Malaria Market Size by Type (2016-2027)
6.3 North America Drugs for Malaria Market Size by Application
6.3.1 North America Drugs for Malaria Market Size by Application (2016-2021)
6.3.2 North America Drugs for Malaria Market Size by Application (2022-2027)
6.3.3 North America Drugs for Malaria Market Size by Application (2016-2027)
6.4 North America Drugs for Malaria Market Size by Country
6.4.1 North America Drugs for Malaria Market Size by Country (2016-2021)
6.4.2 North America Drugs for Malaria Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Drugs for Malaria Market Size (2016-2027)
7.2 Europe Drugs for Malaria Market Size by Type
7.2.1 Europe Drugs for Malaria Market Size by Type (2016-2021)
7.2.2 Europe Drugs for Malaria Market Size by Type (2022-2027)
7.2.3 Europe Drugs for Malaria Market Size by Type (2016-2027)
7.3 Europe Drugs for Malaria Market Size by Application
7.3.1 Europe Drugs for Malaria Market Size by Application (2016-2021)
7.3.2 Europe Drugs for Malaria Market Size by Application (2022-2027)
7.3.3 Europe Drugs for Malaria Market Size by Application (2016-2027)
7.4 Europe Drugs for Malaria Market Size by Country
7.4.1 Europe Drugs for Malaria Market Size by Country (2016-2021)
7.4.2 Europe Drugs for Malaria Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Malaria Market Size (2016-2027)
8.2 Asia-Pacific Drugs for Malaria Market Size by Type
8.2.1 Asia-Pacific Drugs for Malaria Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Drugs for Malaria Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Drugs for Malaria Market Size by Type (2016-2027)
8.3 Asia-Pacific Drugs for Malaria Market Size by Application
8.3.1 Asia-Pacific Drugs for Malaria Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Drugs for Malaria Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Drugs for Malaria Market Size by Application (2016-2027)
8.4 Asia-Pacific Drugs for Malaria Market Size by Region
8.4.1 Asia-Pacific Drugs for Malaria Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Drugs for Malaria Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Drugs for Malaria Market Size (2016-2027)
9.2 Latin America Drugs for Malaria Market Size by Type
9.2.1 Latin America Drugs for Malaria Market Size by Type (2016-2021)
9.2.2 Latin America Drugs for Malaria Market Size by Type (2022-2027)
9.2.3 Latin America Drugs for Malaria Market Size by Type (2016-2027)
9.3 Latin America Drugs for Malaria Market Size by Application
9.3.1 Latin America Drugs for Malaria Market Size by Application (2016-2021)
9.3.2 Latin America Drugs for Malaria Market Size by Application (2022-2027)
9.3.3 Latin America Drugs for Malaria Market Size by Application (2016-2027)
9.4 Latin America Drugs for Malaria Market Size by Country
9.4.1 Latin America Drugs for Malaria Market Size by Country (2016-2021)
9.4.2 Latin America Drugs for Malaria Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Malaria Market Size (2016-2027)
10.2 Middle East & Africa Drugs for Malaria Market Size by Type
10.2.1 Middle East & Africa Drugs for Malaria Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Drugs for Malaria Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Drugs for Malaria Market Size by Type (2016-2027)
10.3 Middle East & Africa Drugs for Malaria Market Size by Application
10.3.1 Middle East & Africa Drugs for Malaria Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Drugs for Malaria Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Drugs for Malaria Market Size by Application (2016-2027)
10.4 Middle East & Africa Drugs for Malaria Market Size by Country
10.4.1 Middle East & Africa Drugs for Malaria Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Drugs for Malaria Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Cipla
11.1.1 Cipla Company Details
11.1.2 Cipla Business Overview
11.1.3 Cipla Drugs for Malaria Introduction
11.1.4 Cipla Revenue in Drugs for Malaria Business (2016-2021)
11.1.5 Cipla Recent Development
11.2 Guilin Pharmaceutical
11.2.1 Guilin Pharmaceutical Company Details
11.2.2 Guilin Pharmaceutical Business Overview
11.2.3 Guilin Pharmaceutical Drugs for Malaria Introduction
11.2.4 Guilin Pharmaceutical Revenue in Drugs for Malaria Business (2016-2021)
11.2.5 Guilin Pharmaceutical Recent Development
11.3 IPCA Laboratories
11.3.1 IPCA Laboratories Company Details
11.3.2 IPCA Laboratories Business Overview
11.3.3 IPCA Laboratories Drugs for Malaria Introduction
11.3.4 IPCA Laboratories Revenue in Drugs for Malaria Business (2016-2021)
11.3.5 IPCA Laboratories Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Drugs for Malaria Introduction
11.4.4 GlaxoSmithKline Revenue in Drugs for Malaria Business (2016-2021)
11.4.5 GlaxoSmithKline Recent Development
11.5 Mylan Labs
11.5.1 Mylan Labs Company Details
11.5.2 Mylan Labs Business Overview
11.5.3 Mylan Labs Drugs for Malaria Introduction
11.5.4 Mylan Labs Revenue in Drugs for Malaria Business (2016-2021)
11.5.5 Mylan Labs Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Drugs for Malaria Introduction
11.6.4 Roche Revenue in Drugs for Malaria Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Drugs for Malaria Introduction
11.7.4 Novartis Revenue in Drugs for Malaria Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Sanofi Aventis
11.8.1 Sanofi Aventis Company Details
11.8.2 Sanofi Aventis Business Overview
11.8.3 Sanofi Aventis Drugs for Malaria Introduction
11.8.4 Sanofi Aventis Revenue in Drugs for Malaria Business (2016-2021)
11.8.5 Sanofi Aventis Recent Development
11.9 Ajanta Pharma
11.9.1 Ajanta Pharma Company Details
11.9.2 Ajanta Pharma Business Overview
11.9.3 Ajanta Pharma Drugs for Malaria Introduction
11.9.4 Ajanta Pharma Revenue in Drugs for Malaria Business (2016-2021)
11.9.5 Ajanta Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Drugs for Malaria Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Aryl Aminoalcohol Compounds
Table 3. Key Players of Antifolate Compounds
Table 4. Key Players of Artemisinin Compounds
Table 5. Global Drugs for Malaria Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Drugs for Malaria Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Drugs for Malaria Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Drugs for Malaria Market Share by Regions (2016-2021)
Table 9. Global Drugs for Malaria Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Drugs for Malaria Market Share by Regions (2022-2027)
Table 11. Drugs for Malaria Market Trends
Table 12. Drugs for Malaria Market Drivers
Table 13. Drugs for Malaria Market Challenges
Table 14. Drugs for Malaria Market Restraints
Table 15. Global Drugs for Malaria Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Drugs for Malaria Market Share by Players (2016-2021)
Table 17. Global Top Drugs for Malaria Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Malaria as of 2020)
Table 18. Ranking of Global Top Drugs for Malaria Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Drugs for Malaria Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Drugs for Malaria Product Solution and Service
Table 22. Date of Enter into Drugs for Malaria Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Drugs for Malaria Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Drugs for Malaria Revenue Market Share by Type (2016-2021)
Table 26. Global Drugs for Malaria Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Drugs for Malaria Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Drugs for Malaria Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Drugs for Malaria Revenue Market Share by Application (2016-2021)
Table 30. Global Drugs for Malaria Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Drugs for Malaria Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Drugs for Malaria Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Drugs for Malaria Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Drugs for Malaria Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Drugs for Malaria Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Drugs for Malaria Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Drugs for Malaria Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Drugs for Malaria Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Drugs for Malaria Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Drugs for Malaria Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Drugs for Malaria Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Drugs for Malaria Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Drugs for Malaria Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Drugs for Malaria Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Drugs for Malaria Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Drugs for Malaria Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Drugs for Malaria Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Drugs for Malaria Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Drugs for Malaria Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Drugs for Malaria Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Drugs for Malaria Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Drugs for Malaria Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Drugs for Malaria Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Drugs for Malaria Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Drugs for Malaria Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Drugs for Malaria Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Drugs for Malaria Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Drugs for Malaria Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Drugs for Malaria Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Drugs for Malaria Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Drugs for Malaria Market Size by Country (2022-2027) & (US$ Million)
Table 62. Cipla Company Details
Table 63. Cipla Business Overview
Table 64. Cipla Drugs for Malaria Product
Table 65. Cipla Revenue in Drugs for Malaria Business (2016-2021) & (US$ Million)
Table 66. Cipla Recent Development
Table 67. Guilin Pharmaceutical Company Details
Table 68. Guilin Pharmaceutical Business Overview
Table 69. Guilin Pharmaceutical Drugs for Malaria Product
Table 70. Guilin Pharmaceutical Revenue in Drugs for Malaria Business (2016-2021) & (US$ Million)
Table 71. Guilin Pharmaceutical Recent Development
Table 72. IPCA Laboratories Company Details
Table 73. IPCA Laboratories Business Overview
Table 74. IPCA Laboratories Drugs for Malaria Product
Table 75. IPCA Laboratories Revenue in Drugs for Malaria Business (2016-2021) & (US$ Million)
Table 76. IPCA Laboratories Recent Development
Table 77. GlaxoSmithKline Company Details
Table 78. GlaxoSmithKline Business Overview
Table 79. GlaxoSmithKline Drugs for Malaria Product
Table 80. GlaxoSmithKline Revenue in Drugs for Malaria Business (2016-2021) & (US$ Million)
Table 81. GlaxoSmithKline Recent Development
Table 82. Mylan Labs Company Details
Table 83. Mylan Labs Business Overview
Table 84. Mylan Labs Drugs for Malaria Product
Table 85. Mylan Labs Revenue in Drugs for Malaria Business (2016-2021) & (US$ Million)
Table 86. Mylan Labs Recent Development
Table 87. Roche Company Details
Table 88. Roche Business Overview
Table 89. Roche Drugs for Malaria Product
Table 90. Roche Revenue in Drugs for Malaria Business (2016-2021) & (US$ Million)
Table 91. Roche Recent Development
Table 92. Novartis Company Details
Table 93. Novartis Business Overview
Table 94. Novartis Drugs for Malaria Product
Table 95. Novartis Revenue in Drugs for Malaria Business (2016-2021) & (US$ Million)
Table 96. Novartis Recent Development
Table 97. Sanofi Aventis Company Details
Table 98. Sanofi Aventis Business Overview
Table 99. Sanofi Aventis Revenue in Drugs for Malaria Business (2016-2021) & (US$ Million)
Table 100. Sanofi Aventis Recent Development
Table 101. Ajanta Pharma Company Details
Table 102. Ajanta Pharma Business Overview
Table 103. Ajanta Pharma Drugs for Malaria Product
Table 104. Ajanta Pharma Revenue in Drugs for Malaria Business (2016-2021) & (US$ Million)
Table 105. Ajanta Pharma Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs for Malaria Market Share by Type: 2020 VS 2027
Figure 2. Aryl Aminoalcohol Compounds Features
Figure 3. Antifolate Compounds Features
Figure 4. Artemisinin Compounds Features
Figure 5. Global Drugs for Malaria Market Share by Application: 2020 VS 2027
Figure 6. Prevention Case Studies
Figure 7. Treatment Case Studies
Figure 8. Others Case Studies
Figure 9. Drugs for Malaria Report Years Considered
Figure 10. Global Drugs for Malaria Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Drugs for Malaria Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Drugs for Malaria Market Share by Regions: 2020 VS 2027
Figure 13. Global Drugs for Malaria Market Share by Regions (2022-2027)
Figure 14. Global Drugs for Malaria Market Share by Players in 2020
Figure 15. Global Top Drugs for Malaria Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Malaria as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Drugs for Malaria Revenue in 2020
Figure 17. Global Drugs for Malaria Revenue Market Share by Type (2016-2021)
Figure 18. Global Drugs for Malaria Revenue Market Share by Type (2022-2027)
Figure 19. North America Drugs for Malaria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Drugs for Malaria Market Share by Type (2016-2027)
Figure 21. North America Drugs for Malaria Market Share by Application (2016-2027)
Figure 22. North America Drugs for Malaria Market Share by Country (2016-2027)
Figure 23. United States Drugs for Malaria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Drugs for Malaria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Drugs for Malaria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Drugs for Malaria Market Share by Type (2016-2027)
Figure 27. Europe Drugs for Malaria Market Share by Application (2016-2027)
Figure 28. Europe Drugs for Malaria Market Share by Country (2016-2027)
Figure 29. Germany Drugs for Malaria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Drugs for Malaria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Drugs for Malaria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Drugs for Malaria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Drugs for Malaria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Drugs for Malaria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Drugs for Malaria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Drugs for Malaria Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Drugs for Malaria Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Drugs for Malaria Market Share by Region (2016-2027)
Figure 39. China Drugs for Malaria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Drugs for Malaria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Drugs for Malaria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Drugs for Malaria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Drugs for Malaria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Drugs for Malaria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Drugs for Malaria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Drugs for Malaria Market Share by Type (2016-2027)
Figure 47. Latin America Drugs for Malaria Market Share by Application (2016-2027)
Figure 48. Latin America Drugs for Malaria Market Share by Country (2016-2027)
Figure 49. Mexico Drugs for Malaria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Drugs for Malaria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Drugs for Malaria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Drugs for Malaria Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Drugs for Malaria Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Drugs for Malaria Market Share by Country (2016-2027)
Figure 55. Turkey Drugs for Malaria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Drugs for Malaria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Drugs for Malaria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Cipla Revenue Growth Rate in Drugs for Malaria Business (2016-2021)
Figure 59. Guilin Pharmaceutical Revenue Growth Rate in Drugs for Malaria Business (2016-2021)
Figure 60. IPCA Laboratories Revenue Growth Rate in Drugs for Malaria Business (2016-2021)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Drugs for Malaria Business (2016-2021)
Figure 62. Mylan Labs Revenue Growth Rate in Drugs for Malaria Business (2016-2021)
Figure 63. Roche Revenue Growth Rate in Drugs for Malaria Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Drugs for Malaria Business (2016-2021)
Figure 65. Sanofi Aventis Revenue Growth Rate in Drugs for Malaria Business (2016-2021)
Figure 66. Ajanta Pharma Revenue Growth Rate in Drugs for Malaria Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
  • Global Dihydroartemisinin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 88
    The global Dihydroartemisinin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2......
  • Global Artemisinin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Artemisinin market size was valued at US$ 61 million in 2023. With growing demand in downstream market, the Artemisinin is forecast to a readjusted size of US$ 227 million by 2030 with a CAGR of 20.7% during review period. The research report highlights the growth potential of the global Artemisinin market. Artemisinin are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......
  • Global Drugs for Malaria Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Drugs for Malaria market size was valued at US$ million in 2023. With growing demand in downstream market, the Drugs for Malaria is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Drugs for Malaria market. Drugs for Malaria are expected to show stable growth in the future market. However, product differentiation, reduc......
  • Dihydroartemisinin - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 99
    The global Dihydroartemisinin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dihydroartemisinin in various end use industries. The expanding demands from the Malaria Treatment, Scientific Research and Others,, are propelling Dihydroartemisinin market. Pharmaceutical Grade, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Global Drugs For Malaria Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Drugs For Malaria market: According to our latest research, the global Drugs For Malaria market looks promising in the next 5 years. As of 2022, the global Drugs For Malaria market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. It is Anti-malarial drug. Anti-malarial drugs are the medicines used to prevent and treat malaria. The malaria is the disease caused due to ......
  • Global Artemisinin Professional Survey Report 2023, Forecast to 2028
    Published: 15-Nov-2023        Price: US 3280 Onwards        Pages: 105
    Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clie......
  • Global Artemisinin Market Research Report 2023, Forecast to 2028
    Published: 15-Nov-2023        Price: US 2680 Onwards        Pages: 131
    Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clie......
  • Global Dihydroartemisinin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 24-Oct-2023        Price: US 3380 Onwards        Pages: 127
    Market Overview of Global Dihydroartemisinin market: According to our latest research, the global Dihydroartemisinin market looks promising in the next 5 years. As of 2022, the global Dihydroartemisinin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dihydroartemisini......
  • Global Artemisinin Market Insights, Forecast to 2029
    Published: 20-Sep-2023        Price: US 4900 Onwards        Pages: 108
    Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast. The global Artemisinin market is projected to grow from US$ 75 million in 2023 to US$ 225.3 million by 2029, at a Compound Annual Growth Rate......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs